On September 7, 2022 AbbVie (NYSE: ABBV) reported that it will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022 (Press release, AbbVie, SEP 7, 2022, View Source [SID1234619125]). Rob Michael, vice chairman and president, Jeff Stewart, executive vice president, commercial operations, and Neil Gallagher, vice president development and chief medical officer will present at 9:35 a.m. Central time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.